Transcept Pharmaceuticals Issues Statement on Dismissal of Derivative Lawsuit
January 13, 2014 at 18:34 PM EST
Transcept Pharmaceuticals (Nasdaq: TSPT ) today announced the dismissal of the derivative lawsuit by the Court of Chancery of the State of Delaware. The derivative lawsuit was filed on October 24, 2013, by a shareholder, Retrophin Inc., against the Transcept Board of Directors, purporting to assert claims on behalf